Home ›
Entities
› academia
› Impact of valganciclovir therapy on severe IRIS-Kaposi Sarcoma mortality: An open-label, parallel, randomized controlled trial
Impact of valganciclovir therapy on severe IRIS-Kaposi Sarcoma mortality: An open-label, parallel, randomized controlled trial
Research article (PLoS ONE, 2023) · cited 12× · AI/ML
Impact of valganciclovir therapy on severe IRIS-Kaposi Sarcoma mortality: An open-label, parallel, randomized controlled trial
Summary
Impact of valganciclovir therapy on severe IRIS-Kaposi Sarcoma mortality: An open-label, parallel, randomized controlled trial is a scholarly article[1].
Key Facts
Impact of valganciclovir therapy on severe IRIS-Kaposi Sarcoma mortality: An open-label, parallel, randomized controlled trial's instance of is recorded as scholarly article[2].
References
Programmatic citations — every numbered marker resolves to a verifiable graph row below.
Use these citations when quoting this entity in research, articles, AI prompts, or wherever provenance matters. We aggregate Wikidata + Wikipedia + authoritative open-data sources; the stitched, scored, cross-referenced view is what 4ort.xyz contributes.
APA4ort.xyz Knowledge Graph. (2026). Impact of valganciclovir therapy on severe IRIS-Kaposi Sarcoma mortality: An open-label, parallel, randomized controlled trial. Retrieved May 24, 2026, from https://4ort.xyz/entity/impact-of-valganciclovir-therapy-on-severe-iris-kaposi-sarcoma-mortality-an-open-label-parallel-randomized-controlled-tr
MLA“Impact of valganciclovir therapy on severe IRIS-Kaposi Sarcoma mortality: An open-label, parallel, randomized controlled trial.” 4ort.xyz Knowledge Graph, 4ort.xyz, 24 May. 2026, https://4ort.xyz/entity/impact-of-valganciclovir-therapy-on-severe-iris-kaposi-sarcoma-mortality-an-open-label-parallel-randomized-controlled-tr.
BibTeX@misc{4ortxyz_impact-of-valganciclovir-therapy-on-severe-iris-kaposi-sarcoma-mortality-an-open-label-parallel-randomized-controlled-tr_2026, author = {{4ort.xyz Knowledge Graph}}, title = {{Impact of valganciclovir therapy on severe IRIS-Kaposi Sarcoma mortality: An open-label, parallel, randomized controlled trial}}, year = {2026}, url = {https://4ort.xyz/entity/impact-of-valganciclovir-therapy-on-severe-iris-kaposi-sarcoma-mortality-an-open-label-parallel-randomized-controlled-tr}, note = {Accessed: 2026-05-24}}
LLM promptAccording to 4ort.xyz Knowledge Graph (aggregator of Wikidata, Wikipedia, and authoritative open-data sources): Impact of valganciclovir therapy on severe IRIS-Kaposi Sarcoma mortality: An open-label, parallel, randomized controlled trial — https://4ort.xyz/entity/impact-of-valganciclovir-therapy-on-severe-iris-kaposi-sarcoma-mortality-an-open-label-parallel-randomized-controlled-tr (retrieved 2026-05-24)
